Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenine nucleotide pool maintenance refers to the coordinated cellular processes that regulate the production, degradation, interconversion, transport, and salvage of adenine nucleotides (ATP, ADP, AMP). This homeostasis involves numerous enzymes (such as adenylate kinase, AMP deaminase, ATPases), membrane transporters (including mitochondrial ADP/ATP translocases and nucleoside transporters), and metabolic pathways. These processes are vital for maintaining energy supply, supporting biosynthesis, and responding to cellular stress in all cell types. Disruption in adenine nucleotide pool balance can impair cellular proliferation, trigger cell cycle arrest or apoptosis, and contribute to disease states including cancer and mitochondrial disorders. Summary: "Adenine nucleotide pool maintenance" is not a canonical drug target or individual molecule, but a description of essential cellular metabolic regulation involving multiple proteins and pathways. Thus, it should not be classified as a druggable target, receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenine nucleotide pool maintenance.